In the excellent recent review article (Ann Clin Biochem 1986; 23: 243-50) on creatinine clearance, Dr Payne discusses the usefulness of plasma creatinine to detect abnormal or changing glomerular function and asks 'can the clinical usefulness of plasma creatinine in each sex be increased by taking account of body size?'. We have recently completed a study on the relationship between body size and plasma creatinine concentration.' In this study, 285 men and 385 women were included and lean body mass was calculated from skinfold thickness. We could not find a significant correlation between plasma creatinine and body weight, lean body mass, or body mass index, and we have argued that with increasing lean body mass the increased production of creatinine is counterbalanced by increasing volume of distribution, i.e. body fluid compartment. Therefore, we suggest that in order to narrow the reference range, other factors such as diet, exercise etc. may have to be studied in detail.
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Predictive value of CK-MB measurement in myocardial infarction
Professor Griffiths I has provided us with a most useful review of the problems involved in the use of CK-MB in the diagnosis of myocardial infarction. Among the many points he makes is one regarding the use of immuno-inhibition tcchniques-vthc diagnostic specificity is greater than the sensitivity, so Letters to the Editor 115 that greater weight can be given to a negative result for excluding the diagnosis than to a positive one in support of the diagnosis of myocardial infarction'.
The Table below illustrates that this is not always the case. I have chosen a specificity value of 95% as a realistic estimate for CK-MB in myocardial infarction, but the same argument applies to all values of 50% or more.
Where diagnostic specificity exceeds sensitivity, the predictive value of a negative result does indeed exceed that of a positive result, but only in a population with a low prevalence of disease. As Professor Griffiths himself points out, the prevalence of acute myocardial infarction in a coronary care unit is in the order of 50%. The Table demonstrates that, under these circumstances, the predictive value of a positive result will almost invariably exceed that of a negative result. This is a clear demonstration that the decision to place greater weight on a positive or a negative result will always depend on the prevalence of the disease being sought in the population under study.
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Fraser, in discussing analytical goals for glucose analysis, draws attention to pre-analytical factors and, rightly. comments that a test result is only as good as the specimen (Ann Clin Biochem 1986; 23: 379-89 
